vs

Side-by-side financial comparison of FOCUS UNIVERSAL INC. (FCUV) and VTEX (VTEX). Click either name above to swap in a different company.

VTEX is the larger business by last-quarter revenue ($42.3K vs $35.3K, roughly 1.2× FOCUS UNIVERSAL INC.). VTEX runs the higher net margin — -18.7% vs -4261.7%, a 4243.0% gap on every dollar of revenue.

Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.

VTEX is a global cloud-based digital commerce platform provider that delivers end-to-end solutions for e-commerce store building, order management, point-of-sale integration, and omnichannel retail operation optimization. It caters to enterprise and mid-sized business clients across retail, consumer goods, manufacturing and other sectors, with core market coverage across Latin America, North America and Europe, helping brands unify online and offline customer shopping experiences.

FCUV vs VTEX — Head-to-Head

Bigger by revenue
VTEX
VTEX
1.2× larger
VTEX
$42.3K
$35.3K
FCUV
Higher net margin
VTEX
VTEX
4243.0% more per $
VTEX
-18.7%
-4261.7%
FCUV

Income Statement — Q2 FY2025 vs Q3 FY2024

Metric
FCUV
FCUV
VTEX
VTEX
Revenue
$35.3K
$42.3K
Net Profit
$-1.5M
$-7.9K
Gross Margin
-35.1%
65.5%
Operating Margin
-4366.7%
Net Margin
-4261.7%
-18.7%
Revenue YoY
214.5%
Net Profit YoY
-10.3%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCUV
FCUV
VTEX
VTEX
Q2 25
$35.3K
Q1 25
$190.3K
Q4 24
$133.2K
Q3 24
$74.2K
$42.3K
Q1 24
$179.5K
Q4 23
$-82.8K
Q3 23
$71.9K
Q2 23
$215.4K
Net Profit
FCUV
FCUV
VTEX
VTEX
Q2 25
$-1.5M
Q1 25
$-1.3M
Q4 24
Q3 24
$1.4M
$-7.9K
Q1 24
$-1.3M
Q4 23
Q3 23
$-968.0K
Q2 23
$-1.0M
Gross Margin
FCUV
FCUV
VTEX
VTEX
Q2 25
-35.1%
Q1 25
16.1%
Q4 24
-95.4%
Q3 24
42.7%
65.5%
Q1 24
50.3%
Q4 23
107.8%
Q3 23
38.2%
Q2 23
30.7%
Operating Margin
FCUV
FCUV
VTEX
VTEX
Q2 25
-4366.7%
Q1 25
-668.3%
Q4 24
-1507.4%
Q3 24
-2353.8%
Q1 24
-676.3%
Q4 23
1869.7%
Q3 23
-1518.7%
Q2 23
-497.5%
Net Margin
FCUV
FCUV
VTEX
VTEX
Q2 25
-4261.7%
Q1 25
-657.7%
Q4 24
Q3 24
1942.9%
-18.7%
Q1 24
-732.9%
Q4 23
Q3 23
-1347.2%
Q2 23
-472.7%
EPS (diluted)
FCUV
FCUV
VTEX
VTEX
Q2 25
Q1 25
$-0.17
Q4 24
$-4.57
Q3 24
$0.02
Q1 24
$-0.20
Q4 23
$-0.73
Q3 23
$-0.01
Q2 23
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCUV
FCUV
VTEX
VTEX
Cash + ST InvestmentsLiquidity on hand
$1.2M
$28.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$845.6K
$240.3M
Total Assets
$1.7M
$341.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCUV
FCUV
VTEX
VTEX
Q2 25
$1.2M
Q1 25
$2.2M
Q4 24
$3.6M
Q3 24
$5.4M
$28.0M
Q1 24
$114.1K
Q4 23
$465.0K
Q3 23
Q2 23
Stockholders' Equity
FCUV
FCUV
VTEX
VTEX
Q2 25
$845.6K
Q1 25
$1.9M
Q4 24
$3.2M
Q3 24
$5.4M
$240.3M
Q1 24
$2.4M
Q4 23
$3.5M
Q3 23
$4.9M
Q2 23
$5.6M
Total Assets
FCUV
FCUV
VTEX
VTEX
Q2 25
$1.7M
Q1 25
$2.7M
Q4 24
$4.1M
Q3 24
$6.2M
$341.1M
Q1 24
$5.0M
Q4 23
$5.3M
Q3 23
$6.4M
Q2 23
$6.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCUV
FCUV
VTEX
VTEX
Operating Cash FlowLast quarter
$-1.4M
$27.3M
Free Cash FlowOCF − Capex
$-1.4M
FCF MarginFCF / Revenue
-4047.4%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCUV
FCUV
VTEX
VTEX
Q2 25
$-1.4M
Q1 25
$-1.2M
Q4 24
$-997.9K
Q3 24
$-1.9M
$27.3M
Q1 24
$-892.1K
Q4 23
$-925.2K
Q3 23
$-996.8K
Q2 23
$-768.2K
Free Cash Flow
FCUV
FCUV
VTEX
VTEX
Q2 25
$-1.4M
Q1 25
$-1.2M
Q4 24
$-1.0M
Q3 24
$-1.9M
Q1 24
$-897.1K
Q4 23
$-925.5K
Q3 23
$-999.9K
Q2 23
$-775.5K
FCF Margin
FCUV
FCUV
VTEX
VTEX
Q2 25
-4047.4%
Q1 25
-653.6%
Q4 24
-753.3%
Q3 24
-2614.6%
Q1 24
-499.8%
Q4 23
1117.8%
Q3 23
-1391.6%
Q2 23
-360.0%
Capex Intensity
FCUV
FCUV
VTEX
VTEX
Q2 25
4.8%
Q1 25
12.3%
Q4 24
4.1%
Q3 24
4.7%
Q1 24
2.8%
Q4 23
-0.4%
Q3 23
4.3%
Q2 23
3.4%
Cash Conversion
FCUV
FCUV
VTEX
VTEX
Q2 25
Q1 25
Q4 24
Q3 24
-1.34×
Q1 24
Q4 23
Q3 23
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons